Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer

NCT01164202 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: sunitinib malate
DRUG: Placebo
PROCEDURE: transarterial chemoembolization

Sponsor

Federation Francophone de Cancerologie Digestive